| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/26/2009 | WO2009036510A1 Novel avian cytokines and genetic sequences encoding same |
| 03/26/2009 | WO2009020964A3 Anti-neublastin antibodies and uses thereof |
| 03/26/2009 | WO2009020933A3 Therapeutic use of anti-tweak receptor antibodies |
| 03/26/2009 | WO2009015908A3 Anti ephb4 antibodies and antibody fragments |
| 03/26/2009 | WO2009005870A3 Products for prophylaxis and/or treatment of viral diseases and method of making and using same |
| 03/26/2009 | WO2008157729A3 Methods for predicting three-dimensional structures for alpha helical membrane proteins and their use in design of selective ligands |
| 03/26/2009 | WO2008151319A3 Expression of soluble antibody fragment by truncation of ch1 domain |
| 03/26/2009 | WO2008112988A3 Apcdd1 inhibitors for treating, diagnosing or detecting cancer |
| 03/26/2009 | WO2008010101A8 Antagonist antibody against epha2 for the treatment of cancer |
| 03/26/2009 | WO2007008547A3 Sp35 antibodies and uses thereof |
| 03/26/2009 | WO2006113050A4 Reagents for the detection of protein phosphorylation in carcinoma signaling pathways |
| 03/26/2009 | WO2005117969A3 Solution phase biopanning method using engineered decoy proteins |
| 03/26/2009 | WO2005072457A3 Humoral response to hip1 in cancer |
| 03/26/2009 | WO2005048917A3 Use of epha4 and modulator or epha4 for diagnosis, treatment and prevention of cancer |
| 03/26/2009 | WO2004093804A3 Human polypeptides encoded by polynucleotides and methods of their use |
| 03/26/2009 | US20090083871 Targeting constructs for the functional disruption of avian immunoglobulin genes |
| 03/26/2009 | US20090083867 Use of Antagonists of Cxcl13 or Cxcr5 for Treating Wounds of Fibrotic Diseases |
| 03/26/2009 | US20090082550 Antibody compositions and methods |
| 03/26/2009 | US20090082549 Sequence encoding amino acids 301-437 of the Fc region of the mouse immunoglobulin e molecule is genetically fused to pseudomonas exotoxin |
| 03/26/2009 | US20090082548 System and method for production of antibodies in plant cell culture |
| 03/26/2009 | US20090082314 Targeting Prodrugs for the Treatment of Gastrointestinal Diseases |
| 03/26/2009 | US20090082303 Drug for preventing and treating atherosclerosis |
| 03/26/2009 | US20090082296 Mycobacterial antigens expressed during latency |
| 03/26/2009 | US20090082294 Diagnosis, prevention and treatment of cancer |
| 03/26/2009 | US20090082273 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 03/26/2009 | US20090082270 myostatin antagonist protein is substantially serum stable for a period of at least 24 hours; treating individuals with muscle wasting conditions and provides further insight into the regulation of myostatin gene expression; muscular disorders |
| 03/26/2009 | US20090082264 123 Human Secreted Proteins |
| 03/26/2009 | US20090081809 Monoclonal antibody specific to dentin-derived heparan sulfate |
| 03/26/2009 | US20090081787 Agent for promoting hepatic cell replication and agent for improving insulin resistance |
| 03/26/2009 | US20090081780 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 03/26/2009 | US20090081732 Antibodies to human il-1beta |
| 03/26/2009 | US20090081730 Activatable recombinant neurotoxins |
| 03/26/2009 | US20090081729 Compositions and Methods Comprising a Ligand of ChemerinR |
| 03/26/2009 | US20090081727 CD33-Like Protein |
| 03/26/2009 | US20090081714 Assays |
| 03/26/2009 | US20090081713 Peptide biomarkers predictive of renal function decline and kidney disease |
| 03/26/2009 | US20090081712 ATM-Dependent Phosphorylation of Sp1 Is Involved in the Cellular Response to DNA Damage and Enhances Cellular Survival After DNA Damage |
| 03/26/2009 | US20090081708 Methods and Compositions for Detection of Ehrlichia chaffeensis (VLPT) |
| 03/26/2009 | US20090081705 Novel peptides and compositions which modulate apoptosis |
| 03/26/2009 | US20090081695 Methods and Compositions for Detection of Ehrlichia chaffeensis (p120) |
| 03/26/2009 | US20090081687 Nucleic Acid Molecules and Other Molecules Associated with Plants |
| 03/26/2009 | US20090081668 Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid |
| 03/26/2009 | US20090081660 Compositions and methods for the diagnosis and treatment of tumor |
| 03/26/2009 | US20090081659 Reagents for the detection of protein phosphorylation in carcinoma signaling pathways |
| 03/26/2009 | US20090081653 A nucleic acid regulating the expression of a gene responsive to insulin where the nucleic acid hybridizes under moderate stringency conditions to a hybridization probe; obesity; insulin-resistance syndrome; antidiabetic and -proliferative |
| 03/26/2009 | US20090081645 Method of assuming drug sensitivity to cdk4 inhibitor |
| 03/26/2009 | US20090081331 Phytase |
| 03/26/2009 | US20090081254 Hiv vaccine for mucosal delivery |
| 03/26/2009 | US20090081242 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 03/26/2009 | US20090081241 comprising all of the heavy chain variable CDR regions of SEQ ID NOS:1, 2 and 3 and/or all of the light chain variable CDR regions of SEQ ID NOS:4, 5 and 6, specific for at least one human tumor necrosis factor alpha (TNF) protein |
| 03/26/2009 | US20090081240 Human Anti-Kir Antibodies |
| 03/26/2009 | US20090081239 bind and neutralize Plasminogen Activator Inhibitor-1 (PAI-1) by converting PAI-1 to its latent form or increasing proteolytic cleavage; treating a fibrotic condition; inhibits accumulation of extracellular matrix (ECM) |
| 03/26/2009 | US20090081238 Anti-notch1 NRR antibodies and methods using same |
| 03/26/2009 | US20090081235 Pseudomonas exotoxin a-like chimeric immunogens for eliciting a secretory iga-mediated immune response |
| 03/26/2009 | US20090081233 Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor |
| 03/26/2009 | US20090081232 Methods of treating diseases with anti-vegf antibodies |
| 03/26/2009 | US20090081230 Human cytomegalovirus neutralising antibodies and use thereof |
| 03/26/2009 | US20090081228 Cyr61 compositions and methods |
| 03/26/2009 | US20090081227 Promotong differentiation of neural stem cells to nerve cells for use in treating injury to central nerve system caused by brain infarction, hemorrhage and/or spinal cord injury |
| 03/26/2009 | US20090081226 Soluble HLA-E Molecules And Their Use For Diagnosing And Treating Pathologies |
| 03/26/2009 | US20090081225 PIF peptides biologic activities, site of action, and the antibody to detect PIF |
| 03/26/2009 | US20090081222 Novel splice variants of the egf receptor |
| 03/26/2009 | US20090081221 Method for suppressing cancer cell metastasis and pharmaceutical composition for use in the method |
| 03/26/2009 | US20090081219 Human monoclonal antibodies against CD25 |
| 03/26/2009 | US20090081218 Fusion proteins |
| 03/26/2009 | US20090081217 Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties |
| 03/26/2009 | US20090081216 Treatment of pathologies which escape the immune response, using optimized antibodies |
| 03/26/2009 | US20090081215 Genetic products differentially expressed in tumors and use thereof |
| 03/26/2009 | US20090081214 Genetic products differentially expressed in tumors and use thereof |
| 03/26/2009 | US20090081211 C3b antibodies and methods for the prevention and treatment of complement-associated disorders |
| 03/26/2009 | US20090081210 Methods of Killing Tumor Cells by Targeting Internal Antigens Exposed on Apoptotic Tumor Cells |
| 03/26/2009 | US20090081209 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like proteins |
| 03/26/2009 | US20090081208 Optimized Fc variants and methods for their generation |
| 03/26/2009 | US20090081207 High affinity human and humanized anti-alpha5beta1 integrin function blocking antibodies with reduced immunogenicity |
| 03/26/2009 | US20090081206 Method and pharmaceutical composition for inhibiting premature rapture of fetal membranes, ripening of uterine cervix and preterm labor in mammals |
| 03/26/2009 | US20090081204 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 03/26/2009 | US20090081202 Immunogenic compositions and methods |
| 03/26/2009 | US20090081200 Tissue Factor Antibodies and Uses Thereof |
| 03/26/2009 | US20090081196 Medicaments for fungal infections |
| 03/26/2009 | US20090081193 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 03/26/2009 | US20090081191 Immunoglobulins; epithelial cell adhesion molecule (EpCAM) |
| 03/26/2009 | US20090081185 Apoptotic agents |
| 03/26/2009 | US20090081161 Treatment of neoplasms with viruses |
| 03/26/2009 | US20090081126 Novel fully human anti-VAP-1 monoclonal antibodies |
| 03/26/2009 | US20090081124 Virus coat protein/receptor chimeras and methods of use |
| 03/26/2009 | US20090078315 Electrode, method of making same, photoelectric transfer element, method of manufacturing same, electronic device and method of manufacturing same |
| 03/26/2009 | CA2700476A1 Methods and compositions for detection of ehrlichia chaffeensis (vlpt) |
| 03/26/2009 | CA2700474A1 Methods and compositions for detection of ehrlichia chaffeensis (p120) |
| 03/26/2009 | CA2700293A1 Method for the preparation of new oligoclonal antibodies |
| 03/26/2009 | CA2700276A1 Inhibition of angiogenesis |
| 03/26/2009 | CA2700128A1 Method of altering the binding specificity of monoclonal antibodies by oxidation-reduction reactions |
| 03/26/2009 | CA2699958A1 Identification and isolation of fetal cells and nucleic acid |
| 03/26/2009 | CA2699944A1 Targeted interferon demonstrates potent apoptotic and anti-tumor activities |
| 03/26/2009 | CA2699760A1 Compositions and methods for diagnosis and treatment of type 2 diabetes |
| 03/26/2009 | CA2699394A1 Internalizing human monoclonal antibodies targeting prostate cancer cells in situ |
| 03/26/2009 | CA2698667A1 Human gm-csf antigen binding proteins |
| 03/26/2009 | CA2696634A1 Monoclonal antibodies against human acidic and basic ferritins and nucleotide and amino acid sequences thereof |
| 03/26/2009 | CA2694494A1 Hpiv-2 variants and medical applications thereof |
| 03/25/2009 | EP2040078A1 Method for quantifying phosphokinase activity on proteins |
| 03/25/2009 | EP2039766A1 Immunocompetent cell having anti-cd38 antibody on its cell surface |